glp-1 arthritis drugs calm inflammation beyond diabetes and weight loss Targeting the GLP-1/GLP-1R axis to
Description
The enzyme originates, in part, from adipocytes, especially those in visceral adipose tissue, as well as from macrophages invading adipose tissue (27)
Asia Pacific is expected to grow at the fastest CAGR between 2026 and 2035
The FDA has approved these agents based on extensive clinical trial data, but post-marketing surveillance continues to refine our understanding of their safety profile, including gastrointestinal and hepatobiliary effects
FIB-4: fibrosis index based on 4 factors
Judges consolidated a large group of Invokana lawsuits in New Jersey multidistrict litigation (MDL) number 2750, and Farxiga lawsuits were transferred to MDL 2776
